The clinical dilemma of JAK inhibitor failure in myelofibrosis: Predictive characteristics and outcomes
Sign Up to like & getrecommendations! Published in 2022 at "Cancer"
DOI: 10.1002/cncr.34222
Abstract: Two Janus‐associated kinase inhibitors (JAKi) (initially ruxolitinib and, more recently, fedratinib) have been approved as treatment options for patients who have intermediate‐risk and high‐risk myelofibrosis (MF), with pivotal trials demonstrating improvements in spleen volume, disease… read more here.
Keywords: clinical dilemma; jaki; inhibitor; myelofibrosis ... See more keywords
Pain management: Opioids for RA: a clinical dilemma
Sign Up to like & getrecommendations! Published in 2017 at "Nature Reviews Rheumatology"
DOI: 10.1038/nrrheum.2017.123
Abstract: Opioids provide some modest pain relief for patients with rheumatoid arthritis, but prescription of these drugs is influenced by their association with risks for the individual and for society. Is denial of a treatment, even… read more here.
Keywords: management opioids; opioids clinical; treatment; pain management ... See more keywords
Median arcuate ligament syndrome: A clinical dilemma
Sign Up to like & getrecommendations! Published in 2021 at "Cleveland Clinic Journal of Medicine"
DOI: 10.3949/ccjm.88a.21001
Abstract: Patients with chronic abdominal pain can benefit from a multidisciplinary evaluation. read more here.
Keywords: medicine; median arcuate; ligament syndrome; arcuate ligament ... See more keywords